The cytosolic
peptide:N-glycanase (PNGase; NGLY1 in humans) is a deglycosylating
enzyme that is widely conserved in eukaryotes. This
enzyme is involved in the degradation of misfolded N-
glycoproteins that are destined for proteasomal degradation in the cytosol, a process that is called endoplasmic reticulum-associated degradation. Although the physiological significance of NGLY1 remained unknown until recently, the discovery of
NGLY1 deficiency, a human
genetic disorder bearing mutations in the NGLY1 gene, has led to
explosive research progress regarding the functional characterization of this
enzyme. For example, it is now known that NGLY1 can also act as an 'editing
enzyme' to convert N-glycosylated
asparagine residues to
aspartate residues, thus introducing negative charges into a core
peptide and modulating the function of the target molecule. Diverse biological processes have also been found to be affected by compromised NGLY1 activity. In this special issue, recent research progress on the functional characterization of NGLY1 and its orthologues in worm/fly/rodents, assay methods/
biomarkers useful for the development of
therapeutics and the comprehensive transcriptome/
proteome of NGLY1-KO cells as well as patient-derived cells are discussed.